Fortrea (FTRE) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Fortrea · Health Care · ref. ETF XLV · 52 calls · price $20.92
What the company does: Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
📈 Fortrea (FTRE) stock price
$20.92+119.1% over range
Oct 14, 25low $8.87 · high $21.11Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
71% recommend buying · 7 analysts
📊 JPI status : Fortrea has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 FTRE price target & analyst consensus — price $20.92
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$26+24.3%
Median target · of 7 targets$23+9.9%
Lowest target · 1 firm of 7$16-23.5%
Current price$20.92
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
686%
$22 ↔ $26
Below
114%
$16
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $22 (+5.2 %), call made on October 1, 2026, maturing on October 1, 2027 (13 d ago).
The 1 reliable analyst
$22+5.2 %
The 6 other firms
$23+9.9 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $22 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy571%
Hold229%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 FTRE price target all
All 52 calls, one by one, with our verdict on each firm.
→ See all 52 targets, analyst by analyst💡 The best analysts on FTRE most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in FTRE? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Fortrea? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on FTRE
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +63.7% | 5 |
| Baird ↗ | 33% | +3.2% | 6 |
| Citigroup ↗ | 0% | -48.5% | 2 |
| Evercore ISI Group ↗ | 0% | -56.8% | 2 |
| Barclays ↗ | 0% | -104.8% | 6 |
📊 What $1,000 invested in Fortrea would be worth › open the full page
In short — $1,000 invested in Fortrea 10 years ago would be worth $599 today, i.e. -16%/yr on average. Best year: 2025 (-13%), worst: 2024 (-45%). Price performance, excluding dividends.
If I'd invested $1,000 in Fortrea
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $935 | -6% |
| 3 years ago | $599 | -40% |
Return by year (Fortrea)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +7% | $1,073 (+7%) |
| 2025 | -13% | $935 (-6%) |
| 2024 | -45% | $517 (-48%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Fortrea
Loading news…
📋 All analyst calls on FTRE
Filtered on — · ✕ show all
▲ Overweight · 🎯$23
Price at call : $20.78 — upside +11%
Today : $20.92 — upside +10%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Oct 6, 27
matures : Oct 6, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $19.95 — gap to target +10%
Today : $20.92 — gap to target +5%
🎯 on FTRE : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Sep 30, 27
matures : Sep 30, 27
▲ Buy · 🎯$23
Price at call : $19.05 — upside +21%
Today : $20.92 — upside +10%
🎯 on FTRE : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Buy · 🎯$22
Price at call : $18.94 — upside +16%
Today : $20.92 — upside +5%
🎯 on FTRE : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 30, 26
▲ Buy · 🎯$26
Price at call : $19.17 — upside +36%
Today : $20.92 — upside +24%
🎯 on FTRE : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Evercore ISI Group ↗
Jul 30, 26
▲ Outperform · 🎯$25
Price at call : $19.17 — upside +30%
Today : $20.92 — upside +20%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $19.08 — gap to target +15%
Today : $20.92 — gap to target +5%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
■ Neutral neutral · not a buy · 🎯$16
Price at call : $17.86 — gap to target -10%
Today : $20.92 — gap to target -24%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
See the other 44 calls, newest to oldest
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $17.02 — gap to target +6%
Today : $20.92 — gap to target -14%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
■ Neutral neutral · not a buy · 🎯$13
Price at call : $14.61 — gap to target -11%
Today : $20.92 — gap to target -38%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
▲ Buy · 🎯$20
Price at call : $15.57 — upside +28%
Today : $20.92 — upside -4%
🎯 on FTRE : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Equal-Weight neutral · not a buy · 🎯$16
Price at call : $15.57 — gap to target +3%
Today : $20.92 — gap to target -24%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Equal-Weight neutral · not a buy · 🎯$11
Price at call : $10.05 — gap to target +9%
Today : $20.92 — gap to target -47%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$14
Price at call : $9.38 — upside +49%
Today : $20.92 — upside -33%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
▲ Buy · 🎯$15
Price at call : $8.95 — upside +68%
Today : $20.92 — upside -28%
🎯 on FTRE : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $10.56 — gap to target +14%
Today : $20.92 — gap to target -43%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
▲ Outperform · 🎯$16
Price at call : $10.72 — upside +49%
Today : $20.92 — upside -24%
🎯 on FTRE : 50% (4 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
■ Hold neutral · not a buy · 🎯$15
Price at call : $16.83 — gap to target -11%
Today : $20.92 — gap to target -28%
🎯 on FTRE : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
Truist Securities ↗
Jan 8, 26
▲ Buy · 🎯$22
Price at call : $17.44 — upside +26%
Today : $20.92 — upside +5%
🎯 on FTRE : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Evercore ISI Group ↗
Jan 6, 26
▲ Outperform · 🎯$25
Price at call : $17.49 — upside +43%
Today : $20.92 — upside +20%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
■ Neutral neutral · not a buy · 🎯$13
Price at call : $16.61 — gap to target -22%
Today : $20.92 — gap to target -38%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $16.06 — gap to target -7%
Today : $20.92 — gap to target -28%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
▲ Buy · 🎯$21
Price at call : $15.55 — upside +35%
Today : $20.92 — upside +0%
🎯 on FTRE : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
▼ Underweight · 🎯$10
Price at call : $11.25 — upside -11%
Today : $20.92 — upside -52%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
■ Neutral neutral · not a buy · 🎯$9
Price at call : $9.45 — gap to target -5%
Today : $20.92 — gap to target -57%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
Evercore ISI Group ↗
Oct 8, 25
■ In-Line neutral · not a buy · 🎯$11
Price at call : $10.13 — gap to target +9%
Today : $20.92 — gap to target -47%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
▼ Underweight · 🎯$8
Price at call : $9.45 — upside -15%
Today : $20.92 — upside -62%
Expected -15% · Actual +123% · Reason (≤ −15%) : ✗ No
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-123.4%
stock +123% · XLV +16%
matured Oct 2, 26
■ Hold neutral · not a buy · 🎯$9.5
Price at call : $10.07 — gap to target -6%
Today : $20.92 — gap to target -55%
🎯 on FTRE : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Sep 9, 26
matures : Sep 9, 26
▲ Outperform · 🎯$14
Price at call : $10.69 — upside +31%
Today : $20.92 — upside -33%
Expected +31% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on FTRE : 50% (4 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+74.2%
stock +74% · XLV +27%
matured Sep 3, 26
Evercore ISI Group ↗
Aug 8, 25
■ In-Line neutral · not a buy · 🎯$7
Price at call : $6.58 — gap to target +6%
Today : $20.92 — gap to target -67%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
▼ Underweight · 🎯$6
Price at call : $7.24 — upside -17%
Today : $20.92 — upside -71%
Expected -17% · Actual +155% · Reason (≤ −15%) : ✗ No
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-154.6%
stock +155% · XLV +28%
matured Aug 7, 26
▲ Outperform · 🎯$9
Price at call : $6.42 — upside +40%
Today : $20.92 — upside -57%
Expected +40% · Actual +180% · Reason (≥ +15%) : ✓ Yes
🎯 on FTRE : 50% (4 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+180.2%
stock +180% · XLV +22%
matured Aug 4, 26
■ Neutral neutral · not a buy · 🎯$7
Price at call : $5.01 — gap to target +40%
Today : $20.92 — gap to target -67%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Jul 11, 26
matures : Jul 11, 26
Evercore ISI Group ↗
Jul 9, 25
■ In-Line neutral · not a buy · 🎯$5
Price at call : $5.04 — gap to target -1%
Today : $20.92 — gap to target -76%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
Goldman Sachs ↗
May 14, 25
■ Neutral neutral · not a buy · 🎯$5
Price at call : $4.75 — gap to target +5%
Today : $20.92 — gap to target -76%
🎯 on FTRE : no call matured yet · 📊 on Health : 51.9% · +5.8% (104 calls)
in progress (365j)
matures : May 14, 26
matures : May 14, 26
■ Neutral neutral · not a buy · 🎯$8
Price at call : $4.75 — gap to target +68%
Today : $20.92 — gap to target -62%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : May 14, 26
matures : May 14, 26
▼ Underweight · 🎯$5
Price at call : $4.78 — upside +5%
Today : $20.92 — upside -76%
Expected +5% · Actual +198% · Reason (≤ −15%) : ✗ No
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-197.9%
stock +198% · XLV +14%
matured May 13, 26
▼ Underweight · 🎯$6
Price at call : $5.21 — upside +15%
Today : $20.92 — upside -71%
Expected +15% · Actual +76% · Reason (≤ −15%) : ✗ No
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-76.2%
stock +76% · XLV +9%
matured Apr 10, 26
■ Neutral neutral · not a buy · 🎯$10
Price at call : $6.45 — gap to target +55%
Today : $20.92 — gap to target -52%
🎯 on FTRE : no call matured yet · 📊 on Health : 27.3% · -9.0% (88 calls)
in progress (365j)
matures : Apr 9, 26
matures : Apr 9, 26
Evercore ISI Group ↗
Mar 4, 25
■ In-Line neutral · not a buy · 🎯$15
Price at call : $10.89 — gap to target +38%
Today : $20.92 — gap to target -28%
🎯 on FTRE : no call matured yet · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Mar 4, 26
matures : Mar 4, 26
Goldman Sachs ↗
Mar 4, 25
■ Neutral neutral · not a buy · 🎯$11
Price at call : $10.96 — gap to target +0%
Today : $20.92 — gap to target -47%
🎯 on FTRE : no call matured yet · 📊 on Health : 51.9% · +5.8% (104 calls)
in progress (365j)
matures : Mar 4, 26
matures : Mar 4, 26
■ Equal-Weight neutral · not a buy · 🎯$12
Price at call : $10.96 — gap to target +9%
Today : $20.92 — gap to target -43%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Mar 4, 26
matures : Mar 4, 26
William Blair ↗
Mar 4, 25
■ Market Perform neutral · not a buy
🎯 on FTRE : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Mar 4, 26
matures : Mar 4, 26
■ Neutral neutral · not a buy · 🎯$23
Price at call : $19.45 — gap to target +18%
Today : $20.92 — gap to target +10%
🎯 on FTRE : no call matured yet · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Dec 11, 25
matures : Dec 11, 25
■ Neutral neutral · not a buy · 🎯$25
Price at call : $21.67 — gap to target +15%
Today : $20.92 — gap to target +20%
🎯 on FTRE : 50% (4 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
in progress (365j)
matures : Dec 6, 25
matures : Dec 6, 25
▲ Outperform · 🎯$28
Price at call : $20.89 — upside +34%
Today : $20.92 — upside +34%
Expected +34% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on FTRE : 50% (4 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
-38.8%
stock -39% · XLV +9%
matured Nov 25, 25
■ Hold neutral · not a buy · 🎯$25
Price at call : $21.95 — gap to target +14%
Today : $20.92 — gap to target +20%
🎯 on FTRE : no call matured yet · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Nov 11, 25
matures : Nov 11, 25
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $22.75 — gap to target +10%
Today : $20.92 — gap to target +20%
🎯 on FTRE : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Nov 11, 25
matures : Nov 11, 25
▲ Outperform · 🎯$30
Price at call : $22.75 — upside +32%
Today : $20.92 — upside +43%
Expected +32% · Actual -48% · Reason (≥ +15%) : ✗ No
🎯 on FTRE : 50% (4 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
-48.2%
stock -48% · XLV +1%
matured Nov 11, 25
William Blair ↗
Nov 8, 24
■ Market Perform neutral · not a buy
🎯 on FTRE : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Nov 8, 25
matures : Nov 8, 25
William Blair ↗
Sep 11, 24
■ Market Perform neutral · not a buy
🎯 on FTRE : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Sep 11, 25
matures : Sep 11, 25
William Blair ↗
Aug 12, 24
■ Market Perform neutral · not a buy
🎯 on FTRE : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Aug 12, 25
matures : Aug 12, 25
Frequently asked questions
Should I buy Fortrea stock?
This isn't buy advice. For Fortrea, the analyst consensus is "Buy", with an average price target of $23.00 (+10% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Fortrea). We show the numbers — you decide.
Is it too late to buy Fortrea? How high can it go?
The most bullish analyst target on Fortrea is $26.00 (+24% above today's price); the average is $23.00. That's the upside they see. Check how reliable those analysts have actually been on Fortrea on our site before trusting it.
Is Fortrea still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 5 analysts have a real record on Fortrea, the best hitting 100% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Fortrea? The case for and against
The arguments for and against, one by one, from the numbers: why invest in FTRE (and why hesitate).
What has Fortrea's past performance been?
Historical returns and a "how much if I had invested" calculator: FTRE performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX